Partnering opportunities

Biomarker companies looking to collaborate

Business and academia from UK and around the world looking to partner to co-develop biomarker technology. We can connect you.

We help ambitious, post-start up businesses, to

  • Move into new markets
  • Access funding
  • Use our networks
  • Innovate to grow
  • Find trusted partners
Innovate UK
HM Government
European Commission

Start new search
Refine

6 total opportunities

Filter your results

I’m looking for a partner...
Country of origin

{[{ data.total | number }]} opportunities

6 opportunities

Get updates to this list

The search results below each have a summary which you may find useful in determining if the opportunity is what you’re looking for.

{[{ row.title }]}

{[{ row.summary }]}

Country of origin {[{ row.country }]}

A novel and multifunctional biomarker for cancer

multifunctional biomarker making it a helpful tool for personalized medicine in cancer treatment, which shall directly improve patient care through early diagnosis of the disease and better adjustment of therapeutic... more

Germany

First biomarker test for the diagnosis of osteoarthritis

-4 in order to strengthen significance of diagnosis (Table 1). Thus the present invention is the first serum biomarker test that helps to support the clinical diagnosis of OA. The university offers a license... more

Germany

Biomarker for efficient prediction and monitoring of tumor necrosis factor alpha in inflammation inhibition therapies

effects and high costs associated to TNF-alpha-blockers treatment. A German research group has generated positive data on the novel use of interleukin-22 binding protein (IL-22BP) as biomarker for the prediction... more

Germany

New biomarkers and technologies for circulating tumor cells (CTC) identification and isolation

circulating tumor cells of phenotype epithelial as circulating tumor cells that present Epithelial-Mesenchymal Transition (EMT) markers using miRNA-21 as a biomarker. The research group is looking for the following... more

Spain

Urinary marker for bladder cancer detection

recurrence rate patients require regular follow-up examinations, currently done by cystoscopy. The new biomarker developed at a Bavarian Research Institute is based on the focal adhesion protein LIM and SH3 (LASP)-1... more

Germany

Early classification of aggressive prostate cancers

is a correlation with the risk for metastasis and the Gleason score, however there is an ongoing search for new biomarkers that directly correlate with the risk for metastasis. A German university discovered vimentin 3 (Vim3) as biomarker more

Germany

The right partner not here?

Get in touch and we'll help you post a partnering opportunity

Hash